共有 1 页
品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|
罗恩 | R023546-50mg | 50mg | 5~7个工作日 |
VX-745 VX-745 |
98% |
|
|
罗恩 | R023546-10mg | 10mg | 5~7个工作日 |
VX-745 VX-745 |
98% |
|
|
罗恩 | R023546-5mg | 5mg | 5~7个工作日 |
VX-745 VX-745 |
98% |
|
|
罗恩 | R023546-1mg | 1mg | 5~7个工作日 |
VX-745 VX-745 |
98% |
|
|
阿拉丁 | V126681-10mg | 10mg | 现货 |
VX-745,p38 alpha MAPK抑制剂 VX-745 |
Moligand™, ≥98% |
|
|
阿拉丁 | V126681-50mg | 50mg | 现货 |
VX-745,p38 alpha MAPK抑制剂 VX-745 |
Moligand™, ≥98% |
|
|
阿拉丁 | V126681-25mg | 25mg | 现货 |
VX-745,p38 alpha MAPK抑制剂 VX-745 |
Moligand™, ≥98% |
|
|
阿拉丁 | V126681-100mg | 100mg | 现货 |
VX-745,p38 alpha MAPK抑制剂 VX-745 |
Moligand™, ≥98% |
|
|
阿拉丁 | V126681-250mg | 250mg | 现货 |
VX-745,p38 alpha MAPK抑制剂 VX-745 |
Moligand™, ≥98% |
|
|
阿拉丁 | V422537-1ml | 1ml | 现货 |
VX-745 VX-745 |
Moligand™, 10mM in DMSO |
|
|
凯为 | JZ002L82-50mg | 50mg | 期货,请咨询 |
5-(2,6-二氯苯基)-2-((2,4-二氟苯基)硫基... 6H-Pyrimido[1,6-b]pyridazin-... |
98% |
|
|
凯为 | JZ002L82-5mg | 5mg | 期货,请咨询 |
5-(2,6-二氯苯基)-2-((2,4-二氟苯基)硫基... 6H-Pyrimido[1,6-b]pyridazin-... |
98% |
|
|
凯为 | JZ002L82-100mg | 100mg | 期货,请咨询 |
5-(2,6-二氯苯基)-2-((2,4-二氟苯基)硫基... 6H-Pyrimido[1,6-b]pyridazin-... |
98% |
|
|
毕得 | BD41447-50mg | 50mg | 现货 |
5-(2,6-二氯苯基)-2-((2,4-二氟苯基)硫基... 5-(2,6-Dichlorophenyl)-2-((2... |
98% |
|
|
毕得 | BD41447-5mg | 5mg | 现货 |
5-(2,6-二氯苯基)-2-((2,4-二氟苯基)硫基... 5-(2,6-Dichlorophenyl)-2-((2... |
98% |
|
|
毕得 | BD41447-100mg | 100mg | 现货 |
5-(2,6-二氯苯基)-2-((2,4-二氟苯基)硫基... 5-(2,6-Dichlorophenyl)-2-((2... |
98% |
|
|
毕得 | BD41447-25mg | 25mg | 现货 |
5-(2,6-二氯苯基)-2-((2,4-二氟苯基)硫基... 5-(2,6-Dichlorophenyl)-2-((2... |
98% |
|
|
Matrix | MA090324-250mg | 250mg | 3-4周 |
5-(2,6-Dichlorophenyl)-2-((2... 5-(2,6-Dichlorophenyl)-2-((2... |
95+% | 咨询 | 请联系客服购买! |
Matrix | MA090324-1g | 1g | 3-4周 |
5-(2,6-Dichlorophenyl)-2-((2... 5-(2,6-Dichlorophenyl)-2-((2... |
95+% | 咨询 | 请联系客服购买! |
Sigma | SML1638-5MG | 5mg | 请咨询 |
(-20°C)VX-745 VX-745 |
咨询 | 请联系客服购买! | |
Sigma | SML1638-25MG | 25mg | 请咨询 |
(-20°C)VX-745 VX-745 |
咨询 | 请联系客服购买! | |
源叶 | S80531-10mg | 10mg | 期货,请咨询 |
VX-745,p38 alpha MAPK抑制剂 VX-745 |
≥98% |
|
|
源叶 | S80531-25mg | 25mg | 期货,请咨询 |
VX-745,p38 alpha MAPK抑制剂 VX-745 |
≥98% |
|
|
源叶 | S80531-100mg | 100mg | 期货,请咨询 |
VX-745,p38 alpha MAPK抑制剂 VX-745 |
≥98% |
|
|
源叶 | S80531-50mg | 50mg | 期货,请咨询 |
VX-745,p38 alpha MAPK抑制剂 VX-745 |
≥98% |
|
|
源叶 | S80531-250mg | 250mg | 期货,请咨询 |
VX-745,p38 alpha MAPK抑制剂 VX-745 |
≥98% |
|
|
源叶 | S57675-1ml | 1ml | 期货,请咨询 |
VX-745 VX-745 |
10mM in DMSO |
|
|
Target Mol | T6089-1mg | 1mg | 现货 |
化合物 Neflamapimod Neflamapimod |
≥95% |
|
|
Target Mol | T6089-5mg | 5mg | 现货 |
化合物 Neflamapimod Neflamapimod |
≥95% |
|
|
Target Mol | T6089-10mg | 10mg | 现货 |
化合物 Neflamapimod Neflamapimod |
≥95% |
|
|
Target Mol | T6089-25mg | 25mg | 现货 |
化合物 Neflamapimod Neflamapimod |
≥95% |
|
|
Target Mol | T6089-50mg | 50mg | 现货 |
化合物 Neflamapimod Neflamapimod |
≥95% |
|
|
Target Mol | T6089-100mg | 100mg | 现货 |
化合物 Neflamapimod Neflamapimod |
≥95% |
|
|
Target Mol | T6089-200mg | 200mg | 现货 |
化合物 Neflamapimod Neflamapimod |
≥95% |
|
|
Target Mol | T6089-1mL | 1mL | 现货 |
化合物 Neflamapimod Neflamapimod |
≥95% |
|
|
Combi | QJ-0680-250mg | 250mg | 请咨询 |
5-(2,6-Dichlorophenyl)-2-((2... 5-(2,6-Dichlorophenyl)-2-((2... |
95% | 咨询 | 请联系客服购买! |
Combi | QJ-0680-1g | 1g | 请咨询 |
5-(2,6-Dichlorophenyl)-2-((2... 5-(2,6-Dichlorophenyl)-2-((2... |
95% | 咨询 | 请联系客服购买! |
Am | A189058-10mg | 10mg | 现货 |
Neflamapimod Neflamapimod |
98% |
|
|
Am | A189058-50mg | 50mg | 现货 |
Neflamapimod Neflamapimod |
98% |
|
|
Am | A189058-5mg | 5mg | 现货 |
Neflamapimod Neflamapimod |
98% |
|
|
MCE | HY-10328-50mg | 50mg | 现货 |
Neflamapimod Neflamapimod |
99.32% |
|
|
MCE | HY-10328-10mg | 10mg | 现货 |
Neflamapimod Neflamapimod |
99.32% |
|
|
MCE | HY-10328-10mM*1mL | 10mM*1mL | 现货 |
Neflamapimod Neflamapimod |
99.32% |
|
|
MCE | HY-10328-5mg | 5mg | 现货 |
Neflamapimod Neflamapimod |
99.32% |
|
|